Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMC 4235028)

Published in Lipids Health Dis on December 05, 2013

Authors

Vanu R Ramprasath, Inbal Eyal, Sigalit Zchut, Peter J H Jones1

Author Affiliations

1: Richardson Centre for Functional Foods and Nutraceuticals, Winnipeg, Canada. peter_jones@umanitoba.ca.

Associated clinical trials:

Krill Oil Study Compared to Fish Oil (Krill) | NCT01323036

Articles citing this

Commentary on a trial comparing krill oil versus fish oil. Lipids Health Dis (2014) 0.98

Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice. Nutr Metab (Lond) (2014) 0.92

A reexamination of krill oil bioavailability studies. Lipids Health Dis (2014) 0.89

ω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary Relevance. Int J Mol Sci (2015) 0.85

Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial. Lipids Health Dis (2015) 0.84

Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults. Lipids Health Dis (2014) 0.81

Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil. Lipids Health Dis (2015) 0.79

Response to commentary on a trial comparing krill oil versus fish oil. Lipids Health Dis (2014) 0.79

Comparison of bioavailability of krill oil versus fish oil and health effect. Vasc Health Risk Manag (2015) 0.78

Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Lipids Health Dis (2015) 0.77

The Effect of Krill Oil Supplementation on Exercise Performance and Markers of Immune Function. PLoS One (2015) 0.76

Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial. Arch Med Sci (2016) 0.76

Effects of krill oil on endothelial function and other cardiovascular risk factors in participants with type 2 diabetes, a randomized controlled trial. BMJ Open Diabetes Res Care (2015) 0.76

A protocol for a randomised controlled trial investigating the effect of increasing Omega-3 index with krill oil supplementation on learning, cognition, behaviour and visual processing in typically developing adolescents. BMJ Open (2016) 0.75

Krill oil extract suppresses cell growth and induces apoptosis of human colorectal cancer cells. BMC Complement Altern Med (2016) 0.75

Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda. Prostaglandins Leukot Essent Fatty Acids (2016) 0.75

Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study. Lipids Health Dis (2015) 0.75

The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil. Lipids Health Dis (2017) 0.75

Redox Status and Neuro Inflammation Indexes in Cerebellum and Motor Cortex of Wistar Rats Supplemented with Natural Sources of Omega-3 Fatty Acids and Astaxanthin: Fish Oil, Krill Oil, and Algal Biomass. Mar Drugs (2015) 0.75

Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial. Lipids Health Dis (2017) 0.75

Articles cited by this

A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet (1999) 13.19

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation (2002) 9.02

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation (1999) 8.13

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med (2004) 3.52

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation (2004) 3.44

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 3.42

n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr (1997) 2.71

Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res (1997) 2.48

Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord (1993) 2.39

Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res (1989) 2.31

Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem (2006) 2.28

Fish consumption and risk of stroke in men. JAMA (2002) 2.08

AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke (2000) 1.90

Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr Res (2002) 1.82

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr (2000) 1.77

The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr (2008) 1.76

Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids (2010) 1.70

Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet (1987) 1.59

Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res (2009) 1.55

Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev (2007) 1.45

Krill for human consumption: nutritional value and potential health benefits. Nutr Rev (2007) 1.40

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr (2009) 1.39

Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur J Clin Nutr (1999) 1.26

Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr (1997) 1.25

Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev (2004) 1.24

Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis (2011) 1.22

Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr (2007) 1.12

Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula. Am J Clin Nutr (1998) 1.02

Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metab (Lond) (2011) 1.02

How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol (2008) 1.00

Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler Thromb (1993) 0.96

N-3 fatty acids: food or supplements? J Am Diet Assoc (2008) 0.95

Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters. Prostaglandins Leukot Essent Fatty Acids (2010) 0.92

A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol (1995) 0.91

Influence of an algal triacylglycerol containing docosahexaenoic acid (22 : 6n-3) and docosapentaenoic acid (22 : 5n-6) on cardiovascular risk factors in healthy men and women. Br J Nutr (2006) 0.89

Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Herz (2004) 0.87

Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev (2003) 0.86

Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease. Int J Cardiol (2001) 0.86

Cardiovascular risk and the omega-3 index. J Cardiovasc Med (Hagerstown) (2007) 0.85

The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr (2006) 0.85

Krill oil. Monograph. Altern Med Rev (2010) 0.85

The relation between fish consumption, death from all causes, and incidence of coronary heart disease. the NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol (2000) 0.84

Treatment of EFA deficiency with dietary triglycerides or phospholipids in a murine model of extrahepatic cholestasis. Am J Physiol Gastrointest Liver Physiol (2003) 0.84

Beneficial effects by intake of Euphausiacea pacifica on high-fat diet-induced obesity. Biol Pharm Bull (2012) 0.80

Comparative effects of dietary corn, fish and Krill oils on intestinal glycosylation. Biochem Mol Biol Int (1994) 0.78

Combination of phytosterols and omega-3 fatty acids: a potential strategy to promote cardiovascular health. Curr Med Chem Cardiovasc Hematol Agents (2004) 0.77